KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Cash & Equivalents (2016 - 2025)

Addus HomeCare's Cash & Equivalents history spans 16 years, with the latest figure at $81.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 17.48% year-over-year to $81.6 million; the TTM value through Dec 2025 reached $81.6 million, down 17.48%, while the annual FY2025 figure was $81.6 million, 17.48% down from the prior year.
  • Cash & Equivalents reached $81.6 million in Q4 2025 per ADUS's latest filing, down from $101.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $222.9 million in Q3 2024 to a low of $64.8 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $113.2 million, with a median of $100.4 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: soared 179.44% in 2024, then tumbled 54.27% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $168.9 million in 2021, then crashed by 52.66% to $80.0 million in 2022, then dropped by 18.97% to $64.8 million in 2023, then skyrocketed by 52.66% to $98.9 million in 2024, then fell by 17.48% to $81.6 million in 2025.
  • Per Business Quant, the three most recent readings for ADUS's Cash & Equivalents are $81.6 million (Q4 2025), $101.9 million (Q3 2025), and $91.2 million (Q2 2025).